Columbia University Irving Medical Center (CUIMC)

Hospital


Location: New York, NY, United States (USA) (US) US

ISNI: 0000000122852675

ROR: https://ror.org/01esghr10

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD (2024) DeFilipp Z, Kim HT, Spyrou N, Katsivelos N, Kowalyk S, Eng G, Kasikis S, et al. Journal article Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD (2024) Etra A, Jurdi NE, Katsivelos N, Kwon D, Gergoudis S, Morales G, Spyrou N, et al. Journal article Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension (2024) Taylor RS, Bentley A, Metcalfe K, Lobo MD, Kirtane AJ, Azizi M, Clark C, et al. Journal article A Day 14 Endpoint for Acute GVHD Clinical Trials (2024) Spyrou N, Akahoshi Y, Kowalyk S, Morales G, Beheshti R, Aguayo-Hiraldo P, Al Malki MM, et al. Journal article Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. (2024) Akahoshi Y, Spyrou N, Hoepting M, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, et al. Journal article Correction to: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension (PharmacoEconomics - Open, (2024), 10.1007/s41669-024-00472-z) (2024) Taylor RS, Bentley A, Metcalfe K, Lobo MD, Kirtane AJ, Azizi M, Clark C, et al. Journal article, Erratum The phenotypic and genotypic spectrum of individuals with mono- or biallelic ANK3 variants (2024) Furia F, Levy AM, Theunis M, Bamshad MJ, Bartos MN, Bijlsma EK, Brancati F, et al. Journal article Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition (2023) Frontera JA, Guekht A, Allegri RF, Ashraf M, Baykan B, Crivelli L, Easton A, et al. Journal article, Review article Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease (2023) Al Malki MM, London K, Baez J, Akahoshi Y, Hogan WJ, Etra A, Choe H, et al. Journal article The utility of biomarkers in acute GVHD prognostication (2023) Spyrou N, Akahoshi Y, Ayuk F, Holler E, Choe H, Etra A, Hogan WJ, et al. Journal article